Search

everythinglearnresearchcommunity

for

Search:↓

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Prolactin may influence skin glands and could be a target for treating acne and skin aging.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Dopamine agonists like pramipexole and ropinirole can cause reversible hair loss.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

Long-term use of oral contraceptives, especially starting before age 20, may increase the risk of early-onset breast cancer.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

Lower baseline prolactin levels may lead to better insulin resistance improvement with metformin in PCOS patients.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

A woman's hair grew back after she stopped taking the Parkinson's disease medication pramipexole.

A teenage girl's excessive hair growth was caused by a medication for mania, but improved after stopping the medication.

ChatGPT-5 can pass the endocrinology exam but isn't fully reliable for clinical decisions yet.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

Prolactin levels are higher in women with hirsutism but don't relate to its severity.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

Latanoprost eye drops caused excessive hair growth and eyelash whitening in a woman.

Prolactin levels and gene polymorphism are not linked to vitiligo severity but are related to BMI.

Finasteride may decrease semen quality but not harm sperm production, and stopping the drug can improve semen quality; hyperprolactinemia can cause infertility but is treatable with medication.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.